Drug intelligence / Profile preview

mepivacaine

Development stage
Approved
Modality
Small Molecules
Administration
Infiltration, Epidural, Perineural, Submucosal
01

Overview

Mepivacaine is an amide-type local anesthetic used for local or regional analgesia or anesthesia. It is chemically related to bupivacaine and pharmacologically similar to lidocaine. Mepivacaine works by stabilizing the neuronal membrane and blocking sodium channels on the intracellular surface of nerve cells. This action prevents the initiation and transmission of nerve impulses required for pain sensation[2][5][8]. It is indicated for infiltration anesthesia (injection into tissue), nerve block (injection near nerves), epidural anesthesia (injection into the epidural space), and dental procedures in both adults and pediatric patients[1][4][5]. Mepivacaine is rapidly metabolized in the liver with a half-life of 1.9–3.2 hours in adults[2][5]. Systemic absorption can affect both cardiovascular and central nervous systems at high concentrations[6].

Brand names
CarbocaineCarbocaine With NeocobefrinIsocaineIsocaine With LevonordefrinPolocaineScandonestScandonest LScandonest PlainPolocaine DENTALPolocaine-MPFCarbocaine HCl
Other names
mepivacaine hydrochloride
02

Targets

NaV alpha (Voltage-gated sodium channel alpha subunit family)SCN10A (Sodium channel protein type X alpha subunit)

Beyond the preview

Go deeper on mepivacaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mepivacaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call